Mark A. Ashwell
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Cancer therapeutics and mechanisms 4
- Receptor Mechanisms and Signaling 3
-
- Sulfur-Based Synthesis Techniques 4
- Synthesis and Reactions of Organic Compounds 3
- Co-authors
- Dennis S. France (6 shared papers)Richard F. W. Jackson (6 shared papers)Chang-Rung Chen (5 shared papers)David Leggett (3 shared papers)Thomas Chan (7 shared papers)Erika Volckova (5 shared papers)Neru Munshi (2 shared papers)Magdi Moussa (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (8 papers)Cancer Research (4 papers)Molecular Cancer Therapeutics (2 papers)SLAS DISCOVERY (2 papers)Tetrahedron (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Mark A. Ashwell
37 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 97
- Hepatology 233
- Toxicology 73
- Organic Chemistry 423
- Molecular Biology 556
- Oncology 206
Countries citing papers authored by Mark A. Ashwell
This map shows the geographic impact of Mark A. Ashwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Ashwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Ashwell more than expected).
Fields of papers citing papers by Mark A. Ashwell
This network shows the impact of papers produced by Mark A. Ashwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Ashwell. The network helps show where Mark A. Ashwell may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Ashwell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 274 | |
| 2 | 2011 | 118 | |
| 3 | 2005 | 112 | |
| 4 | 2004 | 59 | |
| 5 | 2004 | 58 | |
| 6 | 2008 | 51 | |
| 7 | 2011 | 47 | |
| 8 | 2016 | 47 | |
| 9 | 1992 | 47 | |
| 10 | 1991 | 35 | |
| 11 | 1987 | 32 | |
| 12 | 2006 | 29 | |
| 13 | 1987 | 29 | |
| 14 | 2004 | 25 | |
| 15 | 2008 | 25 | |
| 16 | 2004 | 23 | |
| 17 | 2008 | 19 | |
| 18 | ARQ 197, a highly selective small molecule inhibitor of c-Met, with selective antitumor properties in a broad spectrum of human cancer cells | 2007 | 17 |
| 19 | 1990 | 17 | |
| 20 | 1988 | 16 |
About Mark A. Ashwell
Mark A. Ashwell is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Genetics and Pathology and Forensic Medicine, having authored 39 papers that have together received 1.2k indexed citations. Recurring topics across this work include Sulfur-Based Synthesis Techniques (4 papers), Estrogen and related hormone effects (4 papers), Cancer therapeutics and mechanisms (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), Liver physiology and pathology (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Receptor Mechanisms and Signaling (3 papers) and Synthesis and Reactions of Organic Compounds (3 papers). The work is most often cited by research in Hepatology (233 citations), Toxicology (73 citations), Organic Chemistry (423 citations), Molecular Biology (556 citations) and Oncology (206 citations). Mark A. Ashwell has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Dennis S. France, Richard F. W. Jackson, Chang-Rung Chen, David Leggett, Thomas Chan, Erika Volckova, Neru Munshi, Magdi Moussa, Sébastien Jeay and Jason E. Hill. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Cancer Research, Molecular Cancer Therapeutics, SLAS DISCOVERY and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.